Pfizer to merge generics unit with Mylan; seeks to sharpen cancer focus
Drugmaker Pfizer Inc has agreed to spin off its generic drugs business and combine it with Mylan , a move that leaves Pfizer with more profitable innovative drugs, including cancer drug Ibrance and pneumonia vaccine Prevnar.
Wall Street eases from record highs as Fed meeting looms
Wall Street’s main indexes opened below their record highs on Monday, in a muted start to a week likely to be dominated by the Federal Reserve’s policy stance and a round of tech company earnings that will again test the impact of trade concerns on glo…
Wall Street set to open flat as Fed policy meeting looms
U.S. stocks were set to open just off record highs on Monday, pausing at the start of a week likely to be dominated by Wednesday’s statement by the Federal Reserve and a round of tech company earnings that will again test the impact of trade concerns o…
Amazon plans imminent launch of online food delivery service in India: sources
Amazon.com Inc is planning a foray into the burgeoning online food delivery business in India this year, two sources aware of the development said, in a move that could raise competition in an increasingly crowded market.
Shares steady as Fed comes into focus; dollar at two-month high
Global shares steadied on Monday and the dollar hit a two-month high against a basket of currencies as markets counted down to a likely cut in U.S. interest rates this week, with much riding on whether the Federal Reserve signals more cuts will follow….
Exact Sciences to buy Genomic Health for $2.8 billion
Cancer diagnostics company Exact Sciences Corp said on Monday it will buy healthcare company Genomic Health Inc for about $2.8 billion to bolster its cancer testing business.
Oil loses ground on pessimism over U.S.-China trade talks
Oil prices weakened on Monday amid pessimism over U.S.-China trade talks and the prospect of slower economic growth globally that could reduce demand for crude.
Pfizer posts 30% rise in quarterly profit
Pfizer Inc on Monday reported a 30% rise in quarterly profit, helped by demand for its branded treatments such as Ibrance, Eliquis and Xeljanz.
Mylan to combine with Pfizer’s off-patent medicines unit
Pfizer Inc will separate its off-patent drugs business and merge it with Mylan , the two companies confirmed on Monday, bringing blockbuster treatments Viagra, EpiPen and Lipitor under one umbrella.
Top EU court rejects BMW appeal against limit on car plant aid
The European Union’s top court on Monday rejected an appeal by German carmaker BMW against a European Commission decision to limit the state aid it could receive for a car plant in eastern Germany.
